TECHNOLOGY

ABOUT US

CONTACT

OUR MISSION

The FrostBite endoscopic ultrasound (EUS) compatible cryocatheter powered by the GastroCS cryoengine represent a novel Cryoablation Technology Platform. GI Cryo is focused on the commercialization of these minimally-invasive cryoablation devices to target pancreatic tissue via an endoscopic approach. GI Cryo devices have the potential to revolutionize pancreatic cancer and GI tissue ablative therapy 

FrostBite – Powered By GastroCS

EUS comPATIBILITY

+

POWERFUL CRYOGEN

+

PRECISE THERAPEUTIC DELIVERY

Revolutionizing

treatment

possibilities

PANCREATIC CANCER STATISTICS (USA DATA)

American Cancer Society, Cancer Facts & Figures 2020

4th

Leading Cause of Cancer Deaths in U.S.

5-10%

Relative 5 yr. Survival Rate

57,600

New Cases in 2020

47,050

Lives Lost in the U.S. in 2020 alone

Harnessing Technology Advancements to Address Unmet Clinical Needs

Combining the Work Capacity of Liquid Cryogens with the Speed and Control of Gas

TEAM

Bringing GI Cryo’s innovative devices through regulatory approval into the market to impact patient lives is the focused goal of the GI Cryo team.

John M. Baust, Ph. D

Founder and CEO

Kristi K. Snyder, Ph.D

Dir. of Operations

Christen Springs

EndoRx Medical

Building upon the need for new approaches to treat pancreatic cancer and the overall growing clinical acceptance of cryoablation, GI Cryo believes that FrostBite and GastroCS are poised to be a leading technology in gastroenterology

IMPACTING PANCREATIC CANCER

Pancreatic cancer and cysts are often diagnosed by Gastroenterologists using an EUS approach. The ultrasound at the tip of the endoscope permits the physician to visualize pancreatic tissue from inside the stomach. Using the working channel of the EUS scope, Biopsy Needles can be guided to take samples of tissue by accessing the pancreas through the stomach wall. This minimally-invasive method is commonly used to diagnose patients. FrostBite would be the 1st EUS compatible cryoablation tool in Gastroenterologist’s hands to treat tumors and tissues they currently biopsy. 

Therapeutic Tools Designed to work with Advanced Diagnostics

The Future is FrostBite.

opportunity

GI Cryo is opening Investment Opportunities while engaging with Strategic Partners to advance the FrostBite and GastroCS platform technologies.

Contact us for more information. 

Contact Us

We look forward to hearing from you

GI Cryo cannot diagnose or treat patients. Please consult your physician.

Disclaimer: GI Cryo’s technologies are currently Investigational Devices and are limited by Federal Law to  Investigational Use Only.